Skip to main navigation
Skip to search
Skip to main content
Utrecht University Home
Help & FAQ
Link opens in a new tab
Search content at Utrecht University
Home
People
Research units
Research output
Activities
In the media
Prizes & Grants
Biosynthetically engineered lipopolysaccharide as vaccine adjuvant
Afshin Zariri
, Peter van der Ley
Research output
:
Contribution to journal
›
Article
›
Academic
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Biosynthetically engineered lipopolysaccharide as vaccine adjuvant'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Immunology and Microbiology
Adjuvant
100%
Innate Immune System
100%
Adaptive Immune System
100%
Vaccine Adjuvant
100%
Infectious Agent
100%
Immune Response
100%
Bacterial Gene
100%
Bacterial Outer Membrane
100%
Biological Activity
100%
Keyphrases
Lipopolysaccharide
100%
Vaccine Adjuvant
100%
Innate Immune Response
16%
Immune Response
16%
Lipopolysaccharide Biosynthesis
16%
Gram-negative Bacteria
16%
Vaccine Antigen
16%
Adaptive Immune Response
16%
Bacterial Infection
16%
Immunization
16%
Biological Activity
16%
Bacterial Genes
16%
Bacterial Outer Membrane
16%
Exopolysaccharide Structure
16%
Biosynthetic Engineering
16%
Vaccine Immunogenicity
16%
Adjuvant Activity
16%